HemoCue AB Box 1204 262 23 Ängelholm SWEDEN   Phone: +46 77 570 02 10 Fax: +46 77 570 02 12 E-mail: info@hemocue.se    Contact in your country    Online Privacy Policy    Printer friendly	Many women suffer from anemia, mainly due to pregnancy and heavy menstrual periods, bleeding fibroids or endometriosis. To detect the presence of anemia, and assess its severity, measurement of hemoglobin is all that is required. By using the HemoCue Hemoglobin system, the results are available while the patient is still present, and if anemia is detected, sampling for additional laboratory tests can be performed during the same appointment. When the anemia is due to nutritional deficiency, hemoglobin alone provides a sensitive indication of therapeutic response.   Gestational diabetes has been described as a hidden epidemic. It affects 2–4% of pregnant women, but, while treatable, it often remains undiagnosed. When screening for gestational diabetes, glucose measurements must be accurate and precise to ensure high sensitivity and specificity. The HemoCue Glucose systems, with its excellent accuracy and precision, can be used to screen for and diagnose gestational diabetes. Immediate analysis with HemoCue eliminates errors due to glycolysis and increases patient assurance. User's report as pdf